Sharon Townson is CSO at Monte Rosa Therapeutics, Inc. (GLUE). They have made 1 open-market trade across 1 company since 2026, most recently 2026-07-06.
CIK 0001855689
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GLUE | 67,845 | $662K |
Shares reported on the most recent Form 4, priced at the 2026-07-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GLUE | SELL · 10b5-1 | 2026-07-06 | 2026-07-07 | $23.31 | $140K | +2.3% | -34.4% | -57.1% |
| GLUE | SELL · 10b5-1 | 2026-06-23 | 2026-06-25 | $20.00 | $60K | +9.2% | +2.5% | -46.0% |
| GLUE | SELL · 10b5-1 | 2026-06-17 | 2026-06-18 | $19.00 | $57K | +27.0% | +24.3% | -33.1% |
| GLUE | SELL · 10b5-1 | 2026-05-29 | 2026-06-01 | $19.87 | $119K | -10.7% | +25.2% | -27.3% |
| GLUE | SELL | 2026-01-05 | 2026-01-05 | $15.17 | $48K | +69.9% | +37.8% | +19.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.